 <h1>Ganite Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>gallium nitrate</i></p><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li><b class="nav-item here">Side Effects</b></li>
<li>Dosage</li>
<li>Professional</li>
<li>Interactions</li>
<li class="nav-more">
More&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewbox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;
</li>
</ul><ul>
<li>Managing Side Effects</li>
</ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about gallium nitrate. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Ganite.</p><p><i>Applies to gallium nitrate: parenteral injection</i></p><h3>Warning</h3><p><ul>
Concomitant Use with Nephrotoxic Drugs
<li>
Risk of severe renal insufficiency in patients with cancer-related hypercalcemia when administered concomitantly with other potentially nephrotoxic drugs (e.g., aminoglycosides, amphotericin B).&lt;sup&gt;1&lt;/sup&gt;</li></ul></p><ul>
Concomitant Use with Nephrotoxic Drugs
<li>
Risk of severe renal insufficiency in patients with cancer-related hypercalcemia when administered concomitantly with other potentially nephrotoxic drugs (e.g., aminoglycosides, amphotericin B).&lt;sup&gt;1&lt;/sup&gt;</li></ul><p>
<li>
Discontinue gallium if use of a potentially nephrotoxic drug is indicated; continue hydration for several days after administration of the nephrotoxic drug.&lt;sup&gt;1&lt;/sup&gt;  Closely monitor S<sub>cr</sub> and urine output during and after this period.&lt;sup&gt;1&lt;/sup&gt;  If S<sub>cr</sub> exceeds 2.5 mg/dL, discontinue gallium therapy.&lt;sup&gt;1&lt;/sup&gt;</li></p><p></p><p>Side effects include:</p><p>Increased BUN and S<sub>cr</sub>, hypocalcemia, transient hypophosphatemia, decreased serum bicarbonate, decreased BP.  </p><h2>More about Ganite (gallium nitrate)</h2><ul class="more-resources-list more-resources-list-general">
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: miscellaneous bone resorption inhibitors</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Hypercalcemia</li>
<li>Hypercalcemia of Malignancy</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>